問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberVAC18193RSV3001
NCT Number(ClinicalTrials.gov Identfier)-

2021-07-21 - 2023-03-29

Phase III

Recruiting8

ICD-10B97.4

Respiratory syncytial virus as the cause of diseases classified elsewhere

ICD-9079.6

Respiratory syncytial virus(RSV) infections in conditions classified elsewhere and of unspecified site

-

  • Trial Applicant

    IQVIA RDS Taiwan Ltd.

  • Sponsor

    -

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/09/23

Investigators and Locations

Principal Investigator MING-CHE LIU Division of Urology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Tzeng-Ji Chen Division of Family Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Chih Hsueh Lin Division of Geriatrics

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Hui-Shih Cheng Division of General Internal Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Tsong-Yih Ou Division of Infectious Disease

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Po-Liang Lu Division of General Internal Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 王甯祺 Division of Infectious Disease

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Kuo-Chin Huang

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Study Contacts

- -

Condition/Disease

-

Objectives

-

Test Drug

-

Active Ingredient

-

Dosage Form

-

Dosage

-

Endpoints

-

Inclution Criteria

-

Exclusion Criteria

-

The Estimated Number of Participants

  • Taiwan

    270 participants

  • Global

    23000 participants